Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1/2
×
Terminated
×
Advanced or Metastatic Solid Tumors
×
Clear all
Filters
3
NCT03316638
2024-12-10
Ulysse
Pierre Fabre Medicament
Phase 1/2
Terminated
316 enrolled